Cancer encompasses over 100 distinct types, each originating in different tissues and cells. Commonly known cancers include carcinoma, which arises in epithelial cells, and sarcoma, originating in bone, muscle, or connective tissues. Leukemia targets blood-forming tissues, disrupting normal blood cell production, while lymphoma and myeloma impact the immune system by affecting lymph nodes and plasma cells, respectively.
Recent advancements in cancer research are shedding light on rarer types, like neuroendocrine tumors and pediatric-specific cancers. Scientists are exploring molecular and genetic factors that distinguish each type, fostering breakthroughs in personalized medicine. This research is critical for developing targeted therapies that improve survival rates and quality of life for diverse cancer populations.
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : In search of common path in cancerous point mutations
Ratan Kumar Sarkar, Independent Researcher, India
Title : Toll-like receptors-autophagy-PI3Akt “immune-inflammatory metabolic signalosome” in prostate cancer in the robotic prostatectomy golden era: Damage-associated molecular patterns in immunogenic cell-death?
Saumya Pandey, Indira IVF Hospital, India
Title : Revolutionizing psychological care in oncology: A comprehensive review of emerging technologies and their impact on cancer patients
Manijeh Firoozi, University of Tehran, Iran (Islamic Republic of)
Title : A systematic review of medical art therapy for cancer patients
Manijeh Firoozi, University of Tehran, Iran (Islamic Republic of)
Title : Beauty of herbal medicine in the global fight for cancer
Najjemba Eseza Precious, Mengo Senior School, Uganda